Literature DB >> 27308554

The double life of RIPK1.

Lei Jin1, Jiezhong Chen2, Xiao Ying Liu3, Chen Chen Jiang1, Xu Dong Zhang2.   

Abstract

We have recently identified receptor (TNFRSF)-interacting serine-threonine kinase 1 (RIPK1) as an oncogenic driver in melanoma in addition to its well-established role in controlling cell survival and death. Our studies show that RIPK1 promotes melanoma cell proliferation through a positive feedback loop of NFKB1-BIRC2/BIRC3-RIPK1 powered by autocrine tumor necrosis factor.

Entities:  

Keywords:  Cell death; NF-κB; RIPK1; cell proliferation; death receptor; melanoma

Year:  2015        PMID： 27308554      PMCID： PMC4845194          DOI： 10.1080/23723556.2015.1035690

Source DB:  PubMed          Journal:  Mol Cell Oncol        ISSN： 2372-3556


  9 in total

1.  RIP1 Kinase Is an Oncogenic Driver in Melanoma.

Authors:  Xiao Ying Liu; Fritz Lai; Xu Guang Yan; Chen Chen Jiang; Su Tang Guo; Chun Yan Wang; Amanda Croft; Hsin-Yi Tseng; James S Wilmott; Richard A Scolyer; Lei Jin; Xu Dong Zhang
Journal:  Cancer Res       Date:  2015-02-27       Impact factor: 12.701

Review 2.  The role of TNF-alpha in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk.

Authors:  Calin Popa; Mihai G Netea; Piet L C M van Riel; Jos W M van der Meer; Anton F H Stalenhoef
Journal:  J Lipid Res       Date:  2007-01-02       Impact factor: 5.922

Review 3.  Control of life-or-death decisions by RIP1 kinase.

Authors:  Dana E Christofferson; Ying Li; Junying Yuan
Journal:  Annu Rev Physiol       Date:  2013-09-20       Impact factor: 19.318

4.  cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination.

Authors:  Mathieu J M Bertrand; Snezana Milutinovic; Kathleen M Dickson; Wai Chi Ho; Alain Boudreault; Jon Durkin; John W Gillard; James B Jaquith; Stephen J Morris; Philip A Barker
Journal:  Mol Cell       Date:  2008-06-20       Impact factor: 17.970

5.  TNF-alpha induces two distinct caspase-8 activation pathways.

Authors:  Lai Wang; Fenghe Du; Xiaodong Wang
Journal:  Cell       Date:  2008-05-16       Impact factor: 41.582

6.  Comparative expression of NFkappaB proteins in melanocytes of normal skin vs. benign intradermal naevus and human metastatic melanoma biopsies.

Authors:  Susan E McNulty; Raul del Rosario; Dazhi Cen; Frank L Meyskens; Sun Yang
Journal:  Pigment Cell Res       Date:  2004-04

Review 7.  Necroptosis as an alternative form of programmed cell death.

Authors:  Dana E Christofferson; Junying Yuan
Journal:  Curr Opin Cell Biol       Date:  2010-01-04       Impact factor: 8.382

Review 8.  TNF-alpha in promotion and progression of cancer.

Authors:  Frances Balkwill
Journal:  Cancer Metastasis Rev       Date:  2006-09       Impact factor: 9.264

9.  Cytokines and growth factors expressed by human cutaneous melanoma.

Authors:  Elias G Elias; Joanne H Hasskamp; Bhuvnesh K Sharma
Journal:  Cancers (Basel)       Date:  2010-05-07       Impact factor: 6.639
  9 in total
  2 in total

1.  ACTN4 regulates the stability of RIPK1 in melanoma.

Authors:  Yuan Yuan Zhang; Hessam Tabataba; Xiao Ying Liu; Jia Yu Wang; Xu Guang Yan; Margaret Farrelly; Chen Chen Jiang; Su Tang Guo; Tao Liu; Hung-Ying Kao; Rick F Thorne; Xu Dong Zhang; Lei Jin
Journal:  Oncogene       Date:  2018-04-30       Impact factor: 9.867

2.  Cylindromatosis Is Required for Survival of a Subset of Melanoma Cells.

Authors:  Ting La; Lei Jin; Xiao Ying Liu; Ze Hua Song; Margaret Farrelly; Yu Chen Feng; Xu Guang Yan; Yuan Yuan Zhang; Rick F Thorne; Xu Dong Zhang; Liu Teng
Journal:  Oncol Res       Date:  2020-04-06       Impact factor: 5.574
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.